KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Procter & Gamble (PG) Cash & Equivalents (2016 - 2025)

Procter & Gamble (PG) has disclosed Cash & Equivalents for 17 consecutive years, with $10.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 5.82% to $10.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.8 billion, a 5.82% increase, with the full-year FY2025 number at $9.6 billion, up 0.78% from a year prior.
  • Cash & Equivalents was $10.8 billion for Q4 2025 at Procter & Gamble, down from $11.2 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $12.2 billion in Q3 2024 to a low of $6.7 billion in Q3 2022.
  • A 5-year average of $9.2 billion and a median of $9.5 billion in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 40.63% in 2022, then skyrocketed 45.05% in 2023.
  • Procter & Gamble's Cash & Equivalents stood at $11.5 billion in 2021, then crashed by 40.63% to $6.9 billion in 2022, then rose by 15.12% to $7.9 billion in 2023, then rose by 29.66% to $10.2 billion in 2024, then grew by 5.82% to $10.8 billion in 2025.
  • Per Business Quant, the three most recent readings for PG's Cash & Equivalents are $10.8 billion (Q4 2025), $11.2 billion (Q3 2025), and $9.6 billion (Q2 2025).